“…In Caco-2 monolayer models and single pass rat intestinal perfusion models, TSA (Yu et al, 2007a), TSB (Yu et al, 2007b), and CTS (Zhang et al, 2006) are also substrates for P-gp and may also be reversing agents of P-gp. Moreover, TSI, TSA, dihydrotanshinone, and CTS are inhibitors of human CYP1A2, 2C9, 2E1, and 3A4, respectively, with different modes of inhibition (Qiu et al, 2008;Wang et al, 2010a). In addition, single-dose treatment with Danshen increased the clearance of tolbutamide, a CYP2C11 probe drug, and decreased the plasma exposure of 4-hydroxy-tolbutamide in rats (Wang et al, 2010b).…”